炎症性肠病患者根尖周炎患病率:一项回顾性临床研究
这项回顾性临床研究纳入110例接受免疫调节剂或皮质类固醇治疗的炎症性肠病患者,并与110例无全身疾病、未服药的牙科检查者按年龄、性别及体格特征匹配对照,进行完整口腔、牙科及影像学检查。结果显示IBD患者根尖周炎患病率为64%,对照组为59%;女性IBD患者根尖周炎牙数显著高于对照女性(P≤.05),接受生物制剂治疗的女性根尖周炎风险高69%。结论认为接受免疫调节剂的女性IBD患者根尖周炎患病率更高,所有IBD患者病损大于健康者,需进一步研究确认。
要点
- IBD患者根尖周炎患病率为64%,对照组为59%。
- 女性IBD患者根尖周炎牙数显著高于对照女性(P≤.05)。
- 接受生物制剂治疗的女性IBD患者根尖周炎风险高69%。
核心结论
- 接受免疫调节剂的女性IBD患者根尖周炎患病率更高,所有IBD患者病损大于健康者,需进一步研究确认这些发现。
研究设计与样本
- 回顾性临床研究,纳入110例来自大学医院胃肠科接受生物制剂或皮质类固醇治疗的IBD患者(49男、61女,平均年龄46±13.8岁),并与110例无全身疾病、未服药的牙科检查者按年龄、性别及体格特征匹配对照。
主要发现
- 根尖周炎患病率IBD患者为64%,对照组为59%,性别分层分析显示男性组间差异不显著,而女性IBD患者根尖周炎牙数显著高于对照女性(P≤.05)。
- 接受生物制剂治疗的患者根尖周炎患病率为65%,女性根尖周炎风险高69%,且根尖周炎牙数显著更多(P≤.05)。
- 龋失补牙指数两组相似,而IBD患者根尖周指数评分高于对照组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: We evaluated the prevalence of apical periodontitis (AP) and the oral health status in patients with inflammatory bowel diseases (IBDs) treated with immunomodulators, with particular attention to biologic medications (BMs). METHODS: One hundred ten patients, 49 men and 61 women (average age, 46 ± 13.8 years), from the Gastroenterology Unit of the University Hospital with IBDs who were treated with BMs or corticosteroids were included in the study. One hundred ten patients who registered for a dental check-up at the Dental Clinic were matched for age, sex, and physical characteristics with the study group without systemic diseases and not taking medications who were the control. Patients underwent a complete oral, dental, and radiographic examination. Decayed, missing, and filled teeth and periapical index score indexes were recorded. Student t test, χ2, and Mann-Whitney U test were used as appropriate. RESULTS: The prevalence of AP was 64% in IBD patients and 59% in the control; according to the gender-stratified analysis, the difference was not significant among the male groups, whereas the number of teeth with AP was significantly higher in female patients with IBDs than in the controls (P ≤ .05). The prevalence of AP in patients treated with BMs was 65%; women showed 69% higher risk for AP and presented a significantly higher number of teeth with AP (P ≤ .05). Decayed, missing, and filled teeth index was similar in both groups, whereas patients with IBDs had a higher periapical index score than the controls. CONCLUSIONS: Women with IBDs and taking immunomodulators had a higher prevalence of AP. All patients with IBDs had larger lesions than healthy subjects. These data emphasize the influence of the status of the immune system in the onset of AP and the need for further studies to confirm these findings.
引用
- Piras V, Usai P, Mezzena S, et al. Prevalence of Apical Periodontitis in Patients with Inflammatory Bowel Diseases: A Retrospective Clinical Study. J Endod. 2017. PMID: 28231978. doi:10.1016/j.joen.2016.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。